Scholarlink

<p>Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance clinical practice, knowledge, and research on MAFLD, particularly in special groups. The guidelines are designed to advance clinical practice, to provide evidence-based recommendations to assist healthcare stakeholders in decision-making and to improve patient care and disease awareness. The guidelines take into account the burden of clinical management for the healthcare sector.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

  • 期刊论文

  • 发表日期：

    2025年2月27日

查看全文
  • Mohammed Eslam,
  • Jian-Gao Fan,
  • Ming-Lung Yu,
  • Vincent Wai-Sun Wong,
  • Ian Homer Cua,
  • Chun-Jen Liu,
  • Tawesak Tanwandee,
  • Rino Gani,
  • Wai-Kay Seto,
  • Shahinul Alam,
  • Dan Yock Young,
  • Saeed Hamid,
  • Ming-Hua Zheng,
  • Takumi Kawaguchi,
  • Wah-Kheong Chan,
  • Diana Payawal,
  • Soek-Siam Tan,
  • George Boon-bee Goh,
  • Simone I. Strasser,
  • Hang Dao Viet,
  • Jia-Horng Kao,
  • Won Kim,
  • Seung Up Kim,
  • Shelley E. Keating,
  • Yusuf Yilmaz,
  • Lubna Kamani,
  • Chia-Chi Wang,
  • Yasser Fouad,
  • Zaigham Abbas,
  • Sombat Treeprasertsuk,
  • Kessarin Thanapirom,
  • Mamun Al Mahtab,
  • Undram Lkhagvaa,
  • Oidov Baatarkhuu,
  • Ashok Kumar Choudhury,
  • Catherine A. M. Stedman,
  • Abhijit Chowdhury,
  • A Kadir Dokmeci,
  • Fu-Sheng Wang,
  • Han-Chieh Lin,
  • Jee-Fu Huang,
  • Jess Howell,
  • Jidong Jia,
  • Mohamed Alboraie,
  • Stuart K. Roberts,
  • Masato Yoneda,
  • Hasmik Ghazinian,
  • Aram Mirijanyan,
  • Yuemin Nan,
  • Cosmas Rinaldi Adithya Lesmana,
  • Leon A. Adams,
  • Gamal Shiha,
  • Manoj Kumar,
  • Necati Örmeci,
  • Lai Wei,
  • George Lau,
  • Masao Omata,
  • Shiv K. Sarin,
  • Jacob George

摘要

Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association for the Study of the Liver (APASL) has created clinical practice guidelines focused on MAFLD. The guidelines cover various aspects of the disease, such as its epidemiology, diagnosis, screening, assessment, and treatment. The guidelines aim to advance clinical practice, knowledge, and research on MAFLD, particularly in special groups. The guidelines are designed to advance clinical practice, to provide evidence-based recommendations to assist healthcare stakeholders in decision-making and to improve patient care and disease awareness. The guidelines take into account the burden of clinical management for the healthcare sector.